Index RUT
P/E -
EPS (ttm) -4.15
Insider Own 47.91%
Shs Outstand 75.50M
Perf Week 2.17%
Market Cap 1.42B
Forward P/E -
EPS next Y -4.20
Insider Trans 53.01%
Shs Float 47.38M
Perf Month -8.31%
Income -307.00M
PEG -
EPS next Q -1.01
Inst Own 53.87%
Short Float 14.44%
Perf Quarter 1.57%
Sales 117.00M
P/S 12.10
EPS this Y 6.66%
Inst Trans -0.67%
Short Ratio 8.99
Perf Half Y -4.95%
Book/sh 6.12
P/B 2.54
EPS next Y -8.46%
ROA -25.16%
Short Interest 6.84M
Perf Year -20.45%
Cash/sh 8.35
P/C 1.86
EPS next 5Y -
ROE -54.87%
52W Range 12.95 - 25.47
Perf YTD -18.53%
Dividend Est. -
P/FCF -
EPS past 5Y -23.70%
ROI -53.67%
52W High -38.91%
Beta 0.86
Dividend TTM -
Quick Ratio 4.52
Sales past 5Y 164.80%
Gross Margin 86.32%
52W Low 20.15%
ATR (14) 0.84
Dividend Ex-Date -
Current Ratio 4.52
EPS Y/Y TTM -11.90%
Oper. Margin -290.60%
RSI (14) 45.52
Volatility 5.07% 5.39%
Employees 577
Debt/Eq 0.26
Sales Y/Y TTM 4.46%
Profit Margin -262.39%
Recom 1.42
Target Price 38.50
Option/Short Yes / Yes
LT Debt/Eq 0.24
EPS Q/Q -16.23%
Payout -
Rel Volume 0.48
Prev Close 15.95
Sales Surprise 9.54%
EPS Surprise -5.41%
Sales Q/Q -7.89%
Earnings May 08 AMC
Avg Volume 761.13K
Price 15.56
SMA20 -0.85%
SMA50 -9.48%
SMA200 -10.33%
Trades
Volume 366,197
Change -2.45%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-18-22 Initiated
BofA Securities
Neutral
$33
Oct-11-22 Initiated
Morgan Stanley
Overweight
$40
Oct-15-21 Resumed
BTIG Research
Buy
$57
Nov-24-20 Initiated
Berenberg
Buy
$50
Nov-23-20 Initiated
Evercore ISI
Outperform
Apr-03-20 Initiated
Cantor Fitzgerald
Overweight
$21
Mar-04-20 Initiated
Barclays
Overweight
$24
Nov-12-19 Initiated
SunTrust
Buy
$20
Sep-27-19 Initiated
Mizuho
Buy
$22
May-24-19 Resumed
Citigroup
Buy
$25
Oct-09-18 Initiated
Wedbush
Outperform
$22
Apr-09-18 Initiated
Leerink Partners
Outperform
$21
Apr-09-18 Initiated
Goldman
Neutral
$18
Apr-09-18 Initiated
Citigroup
Buy
$18
Show Previous Ratings
May-02-24 04:05PM
May-01-24 10:01AM
Apr-24-24 04:00PM
Apr-23-24 04:05PM
Apr-09-24 04:35PM
07:01PM
Loading…
Mar-29-24 07:01PM
Mar-26-24 04:35PM
Mar-20-24 07:00PM
Mar-11-24 04:35PM
Feb-29-24 03:14AM
Feb-28-24 04:05PM
Feb-27-24 04:35PM
Feb-22-24 11:10AM
09:55AM
07:16AM
(Thomson Reuters StreetEvents)
04:37PM
Loading…
Feb-21-24 04:37PM
04:05PM
Feb-09-24 04:35PM
Feb-07-24 05:00PM
Feb-05-24 12:59PM
Jan-29-24 05:00PM
Jan-26-24 04:35PM
Jan-16-24 05:00PM
Dec-11-23 04:35PM
Dec-04-23 08:00AM
Nov-27-23 04:35PM
Nov-14-23 04:00PM
Nov-13-23 04:35PM
Nov-08-23 04:05PM
Nov-07-23 04:01PM
05:00PM
Loading…
Nov-06-23 05:00PM
Oct-31-23 10:01AM
Oct-24-23 04:35PM
Oct-17-23 04:00PM
Oct-10-23 04:35PM
Sep-27-23 05:14AM
Sep-26-23 04:35PM
Sep-11-23 04:35PM
Sep-05-23 07:37PM
Aug-24-23 04:35PM
11:30AM
09:02AM
Aug-23-23 11:39AM
09:00AM
Aug-09-23 04:35PM
Aug-07-23 09:15AM
08:00AM
Aug-03-23 05:55PM
Aug-02-23 05:25PM
Aug-01-23 05:45PM
Jul-25-23 04:35PM
Jul-11-23 04:35PM
Jul-03-23 06:50AM
Jun-26-23 04:35PM
Jun-21-23 08:00PM
Jun-12-23 12:08PM
Jun-09-23 04:35PM
Jun-05-23 02:59PM
Jun-03-23 01:30PM
May-30-23 04:00PM
May-26-23 04:05PM
(Investor's Business Daily) +25.89%
10:27AM
(Investor's Business Daily)
May-24-23 04:35PM
May-17-23 08:30AM
May-16-23 11:51AM
09:31AM
May-15-23 08:30AM
May-11-23 09:44AM
09:33AM
07:44AM
May-09-23 06:15PM
04:05PM
May-08-23 04:35PM
10:04AM
May-05-23 12:45PM
09:17AM
May-04-23 12:04PM
May-03-23 01:47PM
01:20PM
May-01-23 10:00AM
Apr-26-23 08:00PM
Apr-25-23 04:05PM
Apr-19-23 11:17AM
Apr-11-23 04:05PM
Mar-09-23 04:05PM
Mar-06-23 12:33PM
Mar-03-23 02:20PM
Mar-02-23 04:00PM
Feb-28-23 05:35PM
04:05PM
Feb-24-23 04:05PM
Feb-23-23 01:41PM
Feb-17-23 12:24PM
Feb-15-23 10:57AM
07:50AM
Feb-14-23 06:33AM
Feb-09-23 04:05PM
09:48AM
Feb-08-23 10:53AM
Feb-07-23 12:17PM
Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Jarrett Jennifer Chief Operating Officer Mar 27 '24 Sale 17.55 11,551 202,720 215,253 Mar 29 04:20 PM Jarrett Jennifer Chief Operating Officer Mar 18 '24 Sale 17.92 13,449 240,941 226,804 Mar 20 04:19 PM Jarrett Jennifer Chief Operating Officer Feb 27 '24 Sale 20.11 34,070 685,148 240,253 Feb 28 07:55 PM Jaen Juan C. President Feb 27 '24 Sale 20.10 23,132 464,953 1,188,233 Feb 28 07:55 PM Jarrett Jennifer Chief Operating Officer Feb 26 '24 Sale 20.07 24,555 492,819 274,323 Feb 28 07:55 PM Jaen Juan C. President Feb 26 '24 Sale 20.06 3,900 78,234 1,211,365 Feb 28 07:55 PM GILEAD SCIENCES, INC. 10% Owner Jan 29 '24 Buy 21.00 15,238,095 319,999,995 30,061,124 Jan 31 05:00 PM Jaen Juan C. President Jan 02 '24 Sale 20.09 6,975 140,128 1,215,265 Jan 04 05:22 PM Goeltz II Robert C. Chief Financial Officer Jan 02 '24 Sale 20.00 2,004 40,080 51,831 Jan 04 05:23 PM Jarrett Jennifer Chief Operating Officer Dec 22 '23 Sale 17.76 21,521 382,213 258,878 Dec 26 04:04 PM Azoy Alexander Chief Accounting Officer Dec 01 '23 Sale 14.95 282 4,216 11,596 Dec 05 04:28 PM Jarrett Jennifer Chief Operating Officer Sep 22 '23 Sale 19.99 21,369 427,166 302,691 Sep 26 04:35 PM Jarrett Jennifer Chief Operating Officer Jul 28 '23 Sale 20.25 45,000 911,250 336,566 Jul 31 04:15 PM Azoy Alexander Chief Accounting Officer Jul 03 '23 Sale 20.41 1,018 20,777 11,596 Jul 05 04:05 PM GILEAD SCIENCES, INC. 10% Owner Jun 28 '23 Buy 19.26 1,010,000 19,452,600 14,823,029 Jun 30 03:12 PM Jarrett Jennifer Chief Operating Officer Jun 22 '23 Sale 19.12 12,437 237,795 381,566 Jun 26 04:36 PM Jarrett Jennifer Chief Operating Officer Jun 16 '23 Sale 19.35 12,563 243,094 394,003 Jun 16 08:16 PM Goeltz II Robert C. Chief Financial Officer Jun 07 '23 Sale 20.04 4,049 81,142 59,392 Jun 09 04:05 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite